N/A
Completed N=42
Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate in Healthy Adults
Healthy
Source: ClinicalTrials.gov NCT02017405 ↗
Enrolled (actual)
42
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcomePrimary: Concentration of Total Plasma Amino Acids — 2730.87; 2988.94; 2964.19; 2869.14 umol/mL
Summary
The purpose of this study is to determine the digestibility of serum-derived bovine immunoglobulin protein isolate in healthy adults. The information generated may help elucidate SBI's mechanism of action.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Concentration of Total Plasma Amino Acids |
2730.87; 2988.94; 2964.19; 2869.14; 2723.72; 2785.20 | — |
| SECONDARY Number of Participants With Quantifiable Bovine IgG Plasma Concentration |
0; 0; 0; 1; 0; 0 | — |
| SECONDARY Bovine IgG Concentration in Stool |
100.79; 160.20; 111.59 | — |
Eligibility Criteria
Inclusion Criteria
- Body mass index of 18-32
- Medically normal with no significant abnormal findings at screening
Exclusion Criteria
- Allergy or intolerance to beef
- Participated in another investigational study within 30 days
- Seropostive for HIV, hepatitis B surface antigen, hepatitis C virus
Data sourced from ClinicalTrials.gov (NCT02017405). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.